HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of milnacipran, duloxetine and pregabalin in the formalin pain test and in a model of stress-induced ultrasonic vocalizations in rats.

Abstract
Milnacipran and duloxetine, serotonin/noradrenalin reuptake inhibitors, and pregabalin, a alpha(2)-delta(1) Ca(2+) channel blocker, are efficacious against fibromyalgia, a condition characterized by diffuse chronic pain and associated with stress. We compared these compounds (i.p. route), in rat models of acute/inflammatory pain (2.5% intraplantar formalin) and stress-induced ultrasonic vocalization (USV: 22kHz calls following presentation of a conditioned stimulus previously associated with foot-shocks). In the formalin test, milnacipran dose-dependently attenuated paw elevation and licking (minimal effective dose, MED: 2.5mg/kg for licking/late phase). Duloxetine was slightly more potent (MED=0.63). Pregabalin also reduced paw licking/late phase (MED=0.63), but was inactive up to 160mg/kg for paw elevation (both phases) and paw licking (early phase). Milnacipran dose-dependently reduced USV (MED=10, near total inhibition at 20mg/kg); duloxetine was less potent (MED=20). Pregabalin (2.5-80mg/kg) was only significantly active at 40mg/kg. Milnacipran, duloxetine and pregabalin possess analgesic activity in the formalin test on paw licking/late phase (corresponding to inflammatory pain with a central sensitization component). In the stress-induced USV model, milnacipran was the most potent and efficacious compound. To summarize, reduction of formalin-induced paw licking/late phase might constitute a useful indicator of potential activity against inflammatory/centrally sensitized pain, as might be expressed in fibromyalgia.
AuthorsL Bardin, S Gregoire, M Aliaga, N Malfetes, O Vitton, P Ladure, A Newman-Tancredi, R Depoortère
JournalNeuroscience research (Neurosci Res) Vol. 66 Issue 2 Pg. 135-40 (Feb 2010) ISSN: 1872-8111 [Electronic] Ireland
PMID19883699 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Adrenergic Uptake Inhibitors
  • Analgesics
  • Cyclopropanes
  • Thiophenes
  • Formaldehyde
  • Pregabalin
  • gamma-Aminobutyric Acid
  • Duloxetine Hydrochloride
  • Milnacipran
Topics
  • Adrenergic Uptake Inhibitors (pharmacology)
  • Analgesics (pharmacology)
  • Analysis of Variance
  • Animals
  • Cyclopropanes (pharmacology)
  • Dose-Response Relationship, Drug
  • Duloxetine Hydrochloride
  • Electroshock
  • Formaldehyde (toxicity)
  • Male
  • Milnacipran
  • Pain (chemically induced, drug therapy)
  • Pain Measurement (drug effects)
  • Pregabalin
  • Rats
  • Rats, Sprague-Dawley
  • Stress, Physiological (drug effects)
  • Thiophenes (pharmacology)
  • Vocalization, Animal (drug effects)
  • gamma-Aminobutyric Acid (analogs & derivatives, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: